HCSGD entry for FCGR1A
1. General information
Official gene symbol | FCGR1A |
---|---|
Entrez ID | 2209 |
Gene full name | Fc fragment of IgG, high affinity Ia, receptor (CD64) |
Other gene symbols | CD64 CD64A FCRI IGFR1 |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network

This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0002474 | Antigen processing and presentation of peptide antigen via MHC class I | TAS | biological_process |
GO:0002479 | Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | TAS | biological_process |
GO:0005057 | Receptor signaling protein activity | TAS | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005886 | Plasma membrane | IDA TAS | cellular_component |
GO:0006911 | Phagocytosis, engulfment | TAS | biological_process |
GO:0006955 | Immune response | TAS | biological_process |
GO:0007165 | Signal transduction | TAS | biological_process |
GO:0016021 | Integral component of membrane | IEA | cellular_component |
GO:0019221 | Cytokine-mediated signaling pathway | TAS | biological_process |
GO:0019864 | IgG binding | IEA | molecular_function |
GO:0030669 | Clathrin-coated endocytic vesicle membrane | TAS | cellular_component |
GO:0031901 | Early endosome membrane | TAS | cellular_component |
GO:0035556 | Intracellular signal transduction | TAS | biological_process |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | TAS | biological_process |
GO:0042590 | Antigen processing and presentation of exogenous peptide antigen via MHC class I | TAS | biological_process |
GO:0045087 | Innate immune response | TAS | biological_process |
GO:0060333 | Interferon-gamma-mediated signaling pathway | TAS | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.3515487633 | 0.9224056229 | 0.9999902473 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.1235386877 |
GSE13712_SHEAR | Down | -0.0251984676 |
GSE13712_STATIC | Down | -0.1262713389 |
GSE19018 | Up | 0.2769125808 |
GSE19899_A1 | Up | 0.1843744719 |
GSE19899_A2 | Down | -0.0510974815 |
PubMed_21979375_A1 | Up | 0.2947973479 |
PubMed_21979375_A2 | Up | 0.2073473966 |
GSE35957 | Up | 0.0417640228 |
GSE36640 | Up | 0.2117107627 |
GSE54402 | Up | 0.1162623670 |
GSE9593 | Up | 0.2936316446 |
GSE43922 | - | - |
GSE24585 | - | - |
GSE37065 | - | - |
GSE28863_A1 | Down | -0.0443174351 |
GSE28863_A2 | Down | -0.0404883476 |
GSE28863_A3 | Up | 0.1788237809 |
GSE28863_A4 | Down | -0.0897361504 |
GSE48662 | - | - |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Name | Drug | Accession number |
---|---|---|
Cetuximab | DB00002 | BTD00071 | BIOD00071 |
Etanercept | DB00005 | BTD00052 | BIOD00052 |
Immune Globulin Human | DB00028 | BTD00091 | BIOD00091 |
Adalimumab | DB00051 | BTD00049 | BIOD00049 |
Abciximab | DB00054 | BTD00041 | BIOD00041 |
Gemtuzumab ozogamicin | DB00056 | BTD00077 | BIOD00077 |
Trastuzumab | DB00072 | BTD00098 | BIOD00098 |
Rituximab | DB00073 | BTD00014 | BIOD00014 |
Basiliximab | DB00074 | BTD00073 | BIOD00073 |
Muromonab | DB00075 | BTD00005 | BIOD00005 |
Ibritumomab tiuxetan | DB00078 | BTD00069 | BIOD00069 |
Tositumomab | DB00081 | BTD00085 | BIOD00085 |
Alemtuzumab | DB00087 | BTD00109 | BIOD00109 |
Alefacept | DB00092 | BTD00055 | BIOD00055 |
Efalizumab | DB00095 | BTD00074 | BIOD00074 |
Natalizumab | DB00108 | BTD00083 | BIOD00083 |
Palivizumab | DB00110 | BTD00097 | BIOD00097 |
Daclizumab | DB00111 | BTD00007 | BIOD00007 |
Bevacizumab | DB00112 | BTD00087 | BIOD00087 |
Porfimer | DB00707 | APRD00078 |
Methyl aminolevulinate | DB00992 | APRD01105 |